Singular Genomics Systems Inc (OMIC)
22.77
+0.02
(+0.09%)
USD |
NASDAQ |
Nov 15, 09:40
Singular Genomics Systems Cash from Financing (Quarterly): 0.08M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.08M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.072M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.618M |
| March 31, 2023 | 0.006M |
| December 31, 2022 | 0.75M |
| September 30, 2022 | 0.027M |
| June 30, 2022 | 0.101M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.023M |
| December 31, 2021 | 0.81M |
| September 30, 2021 | -1.32M |
| June 30, 2021 | 239.15M |
| March 31, 2021 | 133.48M |
| December 31, 2020 | 0.028M |
| September 30, 2020 | -0.023M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 7.51M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.32M
Minimum
Sep 2021
239.15M
Maximum
Jun 2021
21.18M
Average
0.05M
Median
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | -2.70M |
| Azenta Inc | -224.44M |
| Harvard Bioscience Inc | 2.104M |
| Bionano Genomics Inc | -1.978M |
| Akoya Biosciences Inc | -2.125M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.04M |
| Cash from Investing (Quarterly) | 23.96M |
| Free Cash Flow | -77.98M |
| Free Cash Flow Per Share (Quarterly) | -7.272 |
| Free Cash Flow to Equity (Quarterly) | -16.77M |
| Free Cash Flow Yield | -139.3% |